Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Publication Type:

Journal Article


Archives of internal medicine, Volume 170, Issue 9, p.765-71 (2010)


2010, Aged, Bone Density, Center-Authored Paper, Female, Fractures, Spontaneous, Humans, Middle Aged, Multivariate Analysis, Osteoporosis, Postmenopause, Proportional Hazards Models, Prospective Studies, Proton Pump Inhibitors, Public Health Sciences Division, Risk Factors, United States


Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. We examined the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]).